Consequences of Undiagnosed and Untreated Pain

Published Online: Thursday, October 20, 2011
Follow Pharmacy_Times:
Watch as Michael R. Clark, MD, MPH, MBA, associate professor and director of the Chronic Pain Treatment Programs and department of Psychiatry and Behavioral Sciences at Johns Hopkins Medical Institutions, talks about the consequences of pain going undiagnosed or untreated—particularly in terms of the impact on quality of life, and the importance of engaging patients early.

Related Articles
Deaths related to oxycodone overdose dropped 25% in Florida after the state adopted a Prescription Drug Monitoring Program to track controlled substance dispensing.
The FDA today expanded the indication of Allergan’s onabotulinumtoxinA (Botox), allowing the drug to be used for the treatment of upper limb spasticity in adults.
In addition to relieving pain, acetaminophen may cause patients to experience less intense emotional responses.
The FDA is warning pharmacists that pets are at risk of death when exposed to topical pain medications containing flurbiprofen.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$